Can a new ultra-long-acting insulin analogue improve patient care? Investigating the potential role of insulin degludec.

Robinson, Jennifer D; Neumiller, Joshua J; Campbell, R Keith

Robinson, Jennifer D; Neumiller, Joshua J; Campbell, R Keith.

Affiliation

Robinson JD; Department of Pharmacotherapy, Washington State University, PO Box 646710, Pullman, WA 99164-6710, USA. jenirobinson@wsu.edu

Drugs ; 72(18): 2319-25, 2012 Dec 24.

Article in En | MEDLINE | ID: mdl-23145524

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/therapeutic use; Insulin, Long-Acting/therapeutic use; Blood Glucose/metabolism; Humans; Hypoglycemic Agents/adverse effects; Insulin, Long-Acting/adverse effects; Patient Care; Randomized Controlled Trials as Topic; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Drugs Year: 2012 Document type: Article Affiliation country: United States Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google